DUSA PHARMACEUTICALS, INC.
NASDAQ : DUSA

DUSA PHARMACEUTICALS, INC.

May 27, 2005 13:18 ET

DUSA Pharmaceuticals To Present At The 9th Annual Friedman Billings Ramsey Growth Investor Conference

WILMINGTON, MASSACHUSETTS--(CCNMatthews - May 27, 2005) - DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announced today that on Wednesday, June 1, 2005, Dr. Geoff Shulman, the Company's
Chairman & Chief Executive Officer will present an overview of the Company at the 9th Annual Friedman Billings Ramsey Growth Investor Conference being held in New York City. The presentation will take place at 3:20 p.m. ET.

Interested parties can access the audio webcast of the presentation on the Company's website at http://www.dusapharma.com

DUSA Pharmaceuticals, Inc. is a biopharmaceutical company engaged primarily in the development and marketing of Levulan Photodynamic Therapy (PDT) and Photodetection (PD) for multiple medical conditions, with a primary focus on dermatology. PDT and PD utilize light-activated compounds to induce a therapeutic or detection effect. DUSA maintains offices in Wilmington, MA, Valhalla, NY and Toronto, Ontario.



Contact Information

  • DUSA Pharmaceuticals, Inc.
    Shari Lovell
    Director, Shareholder Services
    (416) 363-5059
    (416) 363-6602 (FAX)
    http://www.dusapharma.com